Varenicline for Co-occurring Cannabis and Tobacco Use
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
Pilot, eight week, open-label, within-subject cross over trial of four weeks of standard
clinical care (SCC) in an outpatient substance abuse treatment program and four weeks of SCC
and varenicline among current and former tobacco smokers with frequent cannabis use.